Medical Industry - NewsLocker

Next-in-Class Once-Daily Pill Approved for Cystic Fibrosis

Next-in-Class Once-Daily Pill Approved for Cystic Fibrosis

FDA Approves First Sleep Apnea Drug

FDA Approves First Sleep Apnea Drug

FDA OKs Bioengineered Vessel to Reduce Limb Amputations After Vascular Trauma

FDA OKs Bioengineered Vessel to Reduce Limb Amputations After Vascular Trauma

Are Antibiotics Linked to Dementia? New Study Weighs In

Are Antibiotics Linked to Dementia? New Study Weighs In

Public Health Experts Decry Louisiana's Ban on Vaccine Promotion

Public Health Experts Decry Louisiana's Ban on Vaccine Promotion

Flu Season Is Underway, as Cases Surge in Some Areas and Vaccinations Lag

Flu Season Is Underway, as Cases Surge in Some Areas and Vaccinations Lag

First Drug Approved for Familial Chylomicronemia Syndrome

First Drug Approved for Familial Chylomicronemia Syndrome

Employers Press Congress to Cement Health Price Transparency Before Trump's Return

Employers Press Congress to Cement Health Price Transparency Before Trump's Return

Telehealth Pathway for IBD Surgery Expanded Access to Care in Small Study

Telehealth Pathway for IBD Surgery Expanded Access to Care in Small Study

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

What Can Be Done for Severe RSV Cases in Adults?

What Can Be Done for Severe RSV Cases in Adults?

Sticking With CDK4/6 Inhibitors for Breast Cancer Wins in Post-Progression Setting

Sticking With CDK4/6 Inhibitors for Breast Cancer Wins in Post-Progression Setting

A Thin Shred of My Sanity Remained. Then I Hit My Breaking Point.

A Thin Shred of My Sanity Remained. Then I Hit My Breaking Point.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

Randy Moss' Rare GI Cancer: Here's What to Know

Randy Moss' Rare GI Cancer: Here's What to Know